Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc. (NVCT) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 143 transactions totaling $7.3M, demonstrating a bullish sentiment with $7.3M in net insider flow. The most recent transaction on Jan 6, 2026 involved a transaction of 61,200 shares valued at $0.
NVCT Insider Activity Summary
Who Is Buying NVCT Stock?
No significant insider buying has been recorded for NVCT in the recent period.
Who Is Selling NVCT Stock?
No significant insider selling has been recorded for NVCT in the recent period.
Is Nuvectis Pharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for NVCT is bullish with an Insider Alignment Score of 100/100 and a net flow of $7.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
NVCT Frequently Asked Questions
Understanding NVCT Insider Activity
Insider trading at Nuvectis Pharma, Inc. (NVCT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading NVCT stock, having executed 143 transactions in the past 90 days. The most active insider is Marlio Charles Mosseri (Executive), who has made 23 transactions totaling $4.5M.
Related Tools
Track Nuvectis Pharma, Inc. Insider Activity
Get notified when executives and directors at NVCT file new Form 4 transactions